findmyKOL
Clinical trialNCT07190196RecruitingPhase 3Interventional

A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease

SponsorSanofiEnrollment124Immunoglobulin G4 Related Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

79 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Investigational Site Number : 0320005

    Berazategui, Buenos Aires, Argentina

    Recruiting
  • Investigational Site Number : 0320003

    San Isidro, Buenos Aires, Argentina

    Recruiting
  • Investigational Site Number : 0320002

    Resistencia, Chaco Province, Argentina

    Recruiting
  • Investigational Site Number : 0320004

    Buenos Aires, Argentina

    Recruiting
Belgium
  • Investigational Site Number : 0560001

    Leuven, Belgium

    Recruiting
Canada
  • Investigational Site Number : 1240001

    Sherbrooke, Quebec, Canada

    Recruiting
Chile
  • Investigational Site Number : 1520005

    Concepción, Biobio, Chile

    Recruiting
  • Centro de Estudios G Y C-Site Number : 1520003

    Santiago, Reg Metropolitana de Santiago, Chile

    Iván Gónzalez
    Recruiting
  • Investigational Site Number : 1520001

    Santiago, Reg Metropolitana de Santiago, Chile

    Recruiting
  • Investigational Site Number : 1520002

    Santiago, Reg Metropolitana de Santiago, Chile

    Recruiting
  • Investigational Site Number : 1520006

    Santiago, Reg Metropolitana de Santiago, Chile

    Recruiting
China
  • Investigational Site Number : 1560001

    Beijing, China

    Recruiting
  • Investigational Site Number : 1560004

    Beijing, China

    Recruiting
  • Investigational Site Number : 1560008

    Beijing, China

    Recruiting
  • Investigational Site Number : 1560012

    Chengdu, China

    Recruiting
  • Investigational Site Number : 1560010

    Hangzhou, China

    Recruiting
  • Investigational Site Number : 1560003

    Jiazhuang, China

    Recruiting
  • Investigational Site Number : 1560005

    Taiyuan, China

    Recruiting
  • Investigational Site Number : 1560013

    Taiyuan, China

    Recruiting
  • Investigational Site Number : 1560011

    Wuhan, China

    Recruiting
  • Investigational Site Number : 1560009

    Yantai, China

    Recruiting
France
  • Ap-Hp - Hôpital Beaujon-Site Number : 2500002

    Clichy, France

    Active, not recruiting
  • Investigational Site Number : 2500001

    Marseille, France

    Recruiting
  • Chu Bordeaux - Hôpital Haut Leveque-Site Number : 2500003

    Pessac, France

    Active, not recruiting
Germany
  • Investigational Site Number : 2760001

    Berlin, Germany

    Recruiting
  • Investigational Site Number : 2760003

    Erlangen, Germany

    Recruiting
  • Investigational Site Number : 2760004

    Minden, Germany

    Recruiting
  • Investigational Site Number : 2760006

    Ulm, Germany

    Recruiting
Israel
  • Rabin Mc, Outpatient Clinics Building-Site Number : 3760001

    Petah Tikva, Central District, Israel

    Elisheva Pokroy Shapira
    Recruiting
  • Sourasky Rheumatology Dept, Rishonim Building-Site Number : 3760005

    Tel Aviv, Central District, Israel

    Yael Lahat Goldstein
    Recruiting
Italy
  • Aou Meyer Irccs-Site Number : 3800003

    Florence, Firenze, Italy

    Prof. Augusto Vaglio
    Recruiting
  • Irccs Ospedale San Raffaele-Site Number : 3800001

    Milan, Lombardy, Italy

    Prof. Lorenzo Dagna
    Recruiting
  • Centro Ricerche Cliniche Di Verona S.R.L. C/o Policlinico G.B.Rossi-Site Number : 3800002

    Verona, Veneto, Italy

    Prof. Luca Frulloni
    Recruiting
Japan
  • Investigational Site Number : 3920004

    Kitakyushu, Fukuoka, Japan

    Recruiting
  • Hiroshima University Hospital-Site Number : 3920007

    Hiroshima, Hiroshima, Japan

    Shintaro Hirata
    Recruiting
  • Investigational Site Number : 3920011

    Sapporo, Hokkaido, Japan

    Recruiting
  • Kobe University Hospital-Site Number : 3920010

    Kobe, Hyōgo, Japan

    Yuzo Kodama
    Recruiting
  • Kanazawa Medical University Hospital-Site Number : 3920002

    Kahoku, Uchinada, Ishikawa-ken, Japan

    Yasufumi Masaki
    Recruiting
  • Investigational Site Number : 3920001

    Kanazawa, Ishikawa-ken, Japan

    Recruiting
  • Investigational Site Number : 3920005

    Nagaoka, Niigata, Japan

    Recruiting
39 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Sept 2025
Primary completion
28 Jun 2028
Completion
25 Dec 2030
Last update posted
1 Jul 2026
Registered enrollment
124
Registry id
NCT07190196

Cross-registrations

EU-CTR / CTIS (EudraCT)2025-521398-15

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.